Neva SGR

Neva SGR is the venture capital arm of the Intesa Sanpaolo Group and is wholly owned by the Intesa Sanpaolo Innovation Center. It plans and manages investment funds for professional investors seeking diversification and high-yield opportunities through venture capital. By leveraging the resources, know-how, and network of Intesa Sanpaolo Group and its Innovation Center, Neva SGR positions itself at the intersection of finance and technology, supporting Italian innovation and the growth of new technologies while contributing to the development of the venture capital market in Italy.

Matteo Colombo

Investor

Mario Costantini

Managing Director

Marco Di Miceli

Partner, Key Man and Investment Committee Member of NEVA FIRST and NEVA FIRST ITALIA FUNDS

Alberto Graziano

Analyst

Alberto Greppi

Partner

Patrick Guerra

Investor

Niccolò Mussi

Analyst

Cosimo Scarinci

Investor

Past deals in Lisbon

D-Orbit

Series C in 2024
Founded in 2011, D-Orbit is an Italian New Space company specializing in satellite life cycle management. It offers solutions for satellite design, launch, commissioning, and decommissioning, with a focus on safe disposal of artificial satellites at the end of their life to mitigate space debris.

D-Orbit

Series C in 2023
Founded in 2011, D-Orbit is an Italian New Space company specializing in satellite life cycle management. It offers solutions for satellite design, launch, commissioning, and decommissioning, with a focus on safe disposal of artificial satellites at the end of their life to mitigate space debris.

D-Orbit

Series A in 2020
Founded in 2011, D-Orbit is an Italian New Space company specializing in satellite life cycle management. It offers solutions for satellite design, launch, commissioning, and decommissioning, with a focus on safe disposal of artificial satellites at the end of their life to mitigate space debris.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.